Keywords: شیمیدرمانی خوراکی; Oral chemotherapy; Capecitabine; Adverse drug reactions; Serious adverse events; Korea institute of drug safety and risk management; Korean adverse event reporting system database;
مقالات ISI شیمیدرمانی خوراکی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: شیمیدرمانی خوراکی; cancer; economic evaluation; methods; oral chemotherapy; systematic review;
Keywords: شیمیدرمانی خوراکی; caregivers; carers; myeloma; family; experiences; oral chemotherapy; support;
Keywords: شیمیدرمانی خوراکی; Oral chemotherapy; Experiences; Strategies; Grounded theory; Oncology nursing;
Keywords: شیمیدرمانی خوراکی; Monoclonal antibody; Tyrosine kinase inhibitors; Oral chemotherapy; Targeted therapy; Immunotherapy; 2015;
Keywords: شیمیدرمانی خوراکی; Oral chemotherapy; Hematological malignancies; Adherence; Intervention(s); Outcome(s)
Keywords: شیمیدرمانی خوراکی; Patient compliance; Medication adherence; Oral anticancer agents; Oral chemotherapy; Neoplasms; Oncology;
Keywords: شیمیدرمانی خوراکی; Oral chemotherapy; Multiple biobarriers; Emerging trend; Hybrid nanosystems; Integrated
Keywords: شیمیدرمانی خوراکی; Patient compliance; Medication adherence; Oral anticancer agents; Oral chemotherapy; Neoplasms; Oncology; Risk
Validation d'un guide d'entretien pour le suivi des patients traités par chimiothérapie orale
Keywords: شیمیدرمانی خوراکی; chimiothérapie orale; entretien pharmaceutique; oral chemotherapy; pharmaceutical interview;
Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study
Keywords: شیمیدرمانی خوراکی; Bone metastases; Hormone sensitive; Metastatic breast cancer; Oral chemotherapy; Vinorelbine;
Ãlaboration d'un guide standardisé d'informations d'optimisation de l'adhésion médicamenteuse à dispenser lors d'une consultation pharmaceutique au patient atteint de myélome multiple : validation initiale
Keywords: شیمیدرمانی خوراکی; Consultation pharmaceutique; Guide standardisé; Adhésion thérapeutique; Chimiothérapie voie orale; Myélome multiple; Pharmaceutical counseling; Standardized guide; Therapeutic adherence; Oral chemotherapy; Multiple myeloma;
Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment
Keywords: شیمیدرمانی خوراکی; Oral chemotherapy; Metronomic chemotherapy; Chk1 inhibitor; p53-deficient breast cancer; Doxorubicin; Synthetic lethality; MK-8776; Breast cancer;
Adherence, Dosing, and Managing Toxicities With Trifluridine/Tipiracil (TAS-102)
Keywords: شیمیدرمانی خوراکی; Fluoropyrimidine; Metastatic colorectal cancer; Nucleoside analogue; Oral chemotherapy; RECOURSE trial;
Implication du pharmacien dans l'accompagnement des patients sous anticancéreux oraux : état des lieux dans les centres de lutte contre le cancer (CLCC)
Keywords: شیمیدرمانی خوراکی; Observance thérapeutique; Consultation pharmaceutique; Chimiothérapies orales; Prise en charge pluridisciplinaire; Coordination ville-hôpital; Therapeutic adherence; Pharmaceutical consultation; Oral chemotherapy; Multidisciplinary management; Hospital
Original StudyFinal Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer
Keywords: شیمیدرمانی خوراکی; Capecitabine; Combination chemotherapy; Oral chemotherapy; Oral vinorelbine; Taxane doublet;
Facilitating gastrointestinal solubilisation and enhanced oral absorption of SN38 using a molecularly complexed silica-lipid hybrid delivery system
Keywords: شیمیدرمانی خوراکی; 7-Ethyl-10-hydroxycamptothecin (SN38); Lipid-based drug delivery; Oral chemotherapy; SLH; Pharmacokinetics
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles
Keywords: شیمیدرمانی خوراکی; Intestinal permeation; Tamoxifen citrate; Oral chemotherapy; Chitosan; Nanoparticles;
Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine
Keywords: شیمیدرمانی خوراکی; Bevacizumab; Oral chemotherapy; Lymphangitic breast cancer;
Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)
Keywords: شیمیدرمانی خوراکی; Oral chemotherapy; Older patients; Breast cancer; Lung cancer; Colorectal cancer; Metronomic therapy; Vinorelbine; Capecitabine; Bevacizumab
A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity
Keywords: شیمیدرمانی خوراکی; Oral chemotherapy; Polyelectrolyte complex nanoparticles; pH-sensitive; Macromolecular prodrugs; Doxorubicin; Chitosan;
Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel
Keywords: شیمیدرمانی خوراکی; Oral paclitaxel; Ritonavir; Ternary solid dispersion; Oral chemotherapy; Low-dose metronomic chemotherapy; PVP
Oral vinorelbine in metastatic breast cancer: A review of current clinical trial results
Keywords: شیمیدرمانی خوراکی; Oral vinorelbine; Oral chemotherapy; Metastatic breast cancer
Physicians' preferences for prescribing oral and intravenous anticancer drugs: A Discrete Choice Experiment
Keywords: شیمیدرمانی خوراکی; Discrete Choice Experiment; Conjoint analysis; Preference; Medical decision-making; Anticancer drugs; Oral chemotherapy; Intravenous chemotherapy; Chemotherapy administration; Reimbursement;
Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in HER2– Metastatic Breast Cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials
Keywords: شیمیدرمانی خوراکی; Capecitabine; Metastatic breast cancer; Oral chemotherapy; Vinorelbine
Aspectos farmacoeconómicos de los citostáticos orales
Keywords: شیمیدرمانی خوراکی; Quimioterapia oral; Citostáticos; FarmacoeconomÃa; Cumplimiento; Valor; Oral chemotherapy; Cytostatic agents; Pharmacoeconomics; Compliance; Value;
Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001)
Keywords: شیمیدرمانی خوراکی; Docetaxel; Ternary solid dispersion; Oral chemotherapy; PVP; SLS
Interventions to Promote Adherence With Oral Agents
Keywords: شیمیدرمانی خوراکی; Cancer; oral chemotherapy; adherence; symptom management; interventions
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma
Keywords: شیمیدرمانی خوراکی; Temozolomide; Etoposide; Children; Medulloblastoma; Phase I study; Oral chemotherapy;
Poly(lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel
Keywords: شیمیدرمانی خوراکی; Anticancer drugs; Biodegradable polymers; Cancer nanotechnology; Drug delivery device; Oral chemotherapy; Medical clay
Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: A phase II study
Keywords: شیمیدرمانی خوراکی; Vinorelbine; Oral chemotherapy; NSCLC; Consolidation treatment; Cis-platin dose; First-line chemotherapy
Randomized cross-over study of patient preference for oral or intravenous vinorelbine in combination with carboplatin in the treatment of advanced NSCLC
Keywords: شیمیدرمانی خوراکی; Patient preference; Oral chemotherapy; NSCLC; Vinorelbine; Combination chemotherapy; Carboplatin;
Les enjeux de l'observance pour les nouvelles chimiothérapies par voie orale : intérêt du modèle pharmacocinétique-pharmacodynamique
Keywords: شیمیدرمانی خوراکی; non-observance; chimiothérapie orale; oncologie; modèle PK-PD; simulation numérique; non compliance; oral chemotherapy; oncology; PK-PD model; simulation;